ZVRA Q3 2023 Earnings — Zevra Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

ZVRAZevra Therapeutics, Inc.

$618M

Q3 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$3M+0.7% YoY

Gross Profit

$3M95.0% margin

Operating Income

-$15M-530.7% margin

Net Income

-$10M-358.1% margin

EPS (Diluted)

$-0.30

QoQ Revenue Growth

-65.8%

Cash Flow

Operating Cash Flow

-$5M

Free Cash Flow

-$5M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$139M

Total Liabilities

$72M

Stockholders' Equity

$67M

Cash & Equivalents

$43M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3M	$3M	+0.7%
Gross Profit	$3M	$3M	+0.7%
Operating Income	-$15M	-$7M	-131.9%
Net Income	-$10M	-$7M	-56.7%